What is the appropriate intramuscular dosage of ceftriaxone (Rocephin) for adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Rocephin IM Dosage

For adults, administer 1-2 grams intramuscularly once daily (maximum 4 grams/day), and for children, use 50-75 mg/kg once daily (maximum 2 grams/day) for most infections, with specific exceptions for meningitis (100 mg/kg/day) and uncomplicated gonorrhea (250 mg single dose for adults, 50 mg/kg single dose for children with otitis media). 1

Adult Dosing

Standard infections:

  • 1-2 grams IM once daily (or divided twice daily)
  • Maximum daily dose: 4 grams
  • Duration: Continue for at least 2 days after symptom resolution; typical course is 4-14 days 1

Specific indications:

  • Uncomplicated gonorrhea: Single 250 mg IM dose 1
  • Streptococcus pyogenes infections: Continue for minimum 10 days 1

No dose adjustment needed for renal or hepatic impairment in elderly patients receiving up to 2 grams daily, unless severe impairment exists 1

Pediatric Dosing (Beyond Neonatal Period)

Skin and soft tissue infections:

  • 50-75 mg/kg once daily (or divided twice daily)
  • Maximum: 2 grams/day 1

Acute bacterial otitis media:

  • Single IM dose of 50 mg/kg (maximum 1 gram) 1
  • Research supports this single-dose approach, though 3-day regimens show superior eradication of penicillin-resistant S. pneumoniae 2

Serious infections (excluding meningitis):

  • 50-75 mg/kg/day divided every 12 hours
  • Maximum: 2 grams/day 1

Meningitis:

  • Initial dose: 100 mg/kg (maximum 4 grams)
  • Maintenance: 100 mg/kg/day once daily or divided every 12 hours
  • Maximum: 4 grams/day
  • Duration: 7-14 days 1
  • Recent evidence suggests once-daily dosing achieves better CSF penetration than twice-daily for common meningitis pathogens 3

Neonatal Considerations (≤28 Days)

CONTRAINDICATED in neonates requiring calcium-containing IV solutions due to precipitation risk 1

CONTRAINDICATED in premature neonates and hyperbilirubinemic neonates due to bilirubin displacement risk 1

If IV administration is necessary in neonates, infuse over 60 minutes to reduce bilirubin encephalopathy risk 1

Administration Technique

Reconstitution for IM injection:

  • 250 mg vial: Add 0.9 mL diluent → 250 mg/mL concentration
  • 500 mg vial: Add 1.8 mL diluent → 250 mg/mL concentration
  • 1 gram vial: Add 3.6 mL diluent → 250 mg/mL concentration
  • 2 gram vial: Add 7.2 mL diluent → 250 mg/mL concentration 1

Inject deep into large muscle mass with aspiration to avoid intravascular injection 1

Critical Pitfalls

Avoid calcium-containing products: Never mix with calcium-containing IV solutions in neonates. In older patients, sequential administration is acceptable if lines are thoroughly flushed 1

Penicillin-resistant pneumococcus: For otitis media failing initial therapy, consider 3-day IM ceftriaxone regimen (50 mg/kg/day) rather than single dose, as it achieves 97% eradication versus 52% with single dose 2

Meningitis dosing: The 100 mg/kg once-daily regimen achieves superior CSF penetration (88% PTA at 24 hours) compared to 50 mg/kg twice daily (53% PTA) for MIC 1 mg/L pathogens 3

Duration matters: For Streptococcus pyogenes infections, always complete minimum 10-day course regardless of clinical improvement 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.